gip/glp-1 agonist Comparison between GLP-1 RA and the GLP-1/GIP dual GIP (Gastric Inhibitory Polypeptide) Assay

Orforglipron (Eli Lilly) is also an oral GLP-1 RA administered as a once-daily pill for weight loss

EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis

The unapproved product is being evaluated for its use for opioid withdrawal and insomnia

For inflammatory bowel disease, BPC-157 mitigates intestinal inflammation, reduces lesion size, and promotes epithelial lining regeneration

It appears to stimulate the formation of granulation tissue, reepithelialization, and collagen depositionkey phases in the healing process

This is especially useful in high-pressure work or academic settings where sustained attention is required without the jittery effects often associated with caffeine